Event Title
Interventional Management of Portal Hypertension in Cancer Patients
Location
Moultrie, GA
Start Date
4-5-2022 1:00 PM
End Date
4-5-2022 4:00 PM
Description
Introduction:
In the last few decades, there have been significant advancements in understanding the pathophysiology of portal hypertension. This knowledge has led to the development of safer and more effective minimally invasive approaches.
Methods:
This is a literature review that aims to provide an overview of the etiology and hallmarks of common cancer-related conditions that contribute to the high incidence of portal hypertension and describes how interventional radiology is uniquely positioned to help in its management.
Results:
The causes of portal hypertension can be classified as prehepatic, intrahepatic (presinusoidal, sinusoidal, and post-sinusoidal), and posthepatic. This is based on the level of obstruction of the portal circulation and there are oncologic conditions associated with each category. Current interventional management centers on control and prophylaxis of portal hypertension related complications including bleeding, ascites, and thrombocytopenia. Interventional radiology plays a central role in improving survival of these patients.
Discussion:
Clinicians involved in cancer care should be aware of risk factors, associated complications, and management of portal hypertension in cancer patients. Interventional radiology offers minimally invasive alternatives that play a central role in improving clinical outcomes and survival of these patients, allowing continuation of cancer treatments.
Embargo Period
5-31-2022
Interventional Management of Portal Hypertension in Cancer Patients
Moultrie, GA
Introduction:
In the last few decades, there have been significant advancements in understanding the pathophysiology of portal hypertension. This knowledge has led to the development of safer and more effective minimally invasive approaches.
Methods:
This is a literature review that aims to provide an overview of the etiology and hallmarks of common cancer-related conditions that contribute to the high incidence of portal hypertension and describes how interventional radiology is uniquely positioned to help in its management.
Results:
The causes of portal hypertension can be classified as prehepatic, intrahepatic (presinusoidal, sinusoidal, and post-sinusoidal), and posthepatic. This is based on the level of obstruction of the portal circulation and there are oncologic conditions associated with each category. Current interventional management centers on control and prophylaxis of portal hypertension related complications including bleeding, ascites, and thrombocytopenia. Interventional radiology plays a central role in improving survival of these patients.
Discussion:
Clinicians involved in cancer care should be aware of risk factors, associated complications, and management of portal hypertension in cancer patients. Interventional radiology offers minimally invasive alternatives that play a central role in improving clinical outcomes and survival of these patients, allowing continuation of cancer treatments.